nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—CHRM3—nephrolithiasis	0.951	1	CbGaD
Mepenzolate—CHRM3—ureter—nephrolithiasis	0.0132	0.865	CbGeAlD
Mepenzolate—CHRM1—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00504	0.196	CbGpPWpGaD
Mepenzolate—CHRM2—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00497	0.194	CbGpPWpGaD
Mepenzolate—Diphemanil Methylsulfate—CHRM3—nephrolithiasis	0.00158	0.194	CrCbGaD
Mepenzolate—Aclidinium—CHRM3—nephrolithiasis	0.00127	0.156	CrCbGaD
Mepenzolate—CHRM1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00111	0.0433	CbGpPWpGaD
Mepenzolate—CHRM2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0011	0.0428	CbGpPWpGaD
Mepenzolate—CHRM3—renal system—nephrolithiasis	0.00105	0.0688	CbGeAlD
Mepenzolate—Clidinium—CHRM3—nephrolithiasis	0.00104	0.127	CrCbGaD
Mepenzolate—CHRM3—kidney—nephrolithiasis	0.00102	0.0665	CbGeAlD
Mepenzolate—Trospium—CHRM3—nephrolithiasis	0.000999	0.123	CrCbGaD
Mepenzolate—CHRM1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.000936	0.0364	CbGpPWpGaD
Mepenzolate—CHRM2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.000924	0.036	CbGpPWpGaD
Mepenzolate—Glycopyrrolate—CHRM3—nephrolithiasis	0.000913	0.112	CrCbGaD
Mepenzolate—Isopropamide—CHRM3—nephrolithiasis	0.000882	0.108	CrCbGaD
Mepenzolate—Diphenidol—CHRM3—nephrolithiasis	0.000731	0.0898	CrCbGaD
Mepenzolate—Darifenacin—CHRM3—nephrolithiasis	0.000725	0.0891	CrCbGaD
Mepenzolate—CHRM1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000683	0.0266	CbGpPWpGaD
Mepenzolate—CHRM3—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000681	0.0265	CbGpPWpGaD
Mepenzolate—CHRM2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000674	0.0262	CbGpPWpGaD
Mepenzolate—CHRM2—GPCRs, Other—CHRM3—nephrolithiasis	0.000488	0.019	CbGpPWpGaD
Mepenzolate—CHRM2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000468	0.0182	CbGpPWpGaD
Mepenzolate—CHRM1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000385	0.015	CbGpPWpGaD
Mepenzolate—CHRM3—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000383	0.0149	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000344	0.0134	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000343	0.0133	CbGpPWpGaD
Mepenzolate—CHRM1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000333	0.013	CbGpPWpGaD
Mepenzolate—CHRM1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000333	0.013	CbGpPWpGaD
Mepenzolate—CHRM2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000329	0.0128	CbGpPWpGaD
Mepenzolate—CHRM2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000329	0.0128	CbGpPWpGaD
Mepenzolate—CHRM1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000278	0.0108	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000249	0.00968	CbGpPWpGaD
Mepenzolate—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000215	0.00837	CbGpPWpGaD
Mepenzolate—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000212	0.00826	CbGpPWpGaD
Mepenzolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000184	0.00717	CbGpPWpGaD
Mepenzolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000182	0.00708	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000162	0.00632	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—RGS14—nephrolithiasis	0.000162	0.0063	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00016	0.00623	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.000147	0.00574	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—RGS14—nephrolithiasis	0.000147	0.00572	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.000145	0.00566	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00014	0.00546	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000138	0.00539	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—PTH—nephrolithiasis	0.000128	0.00499	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—PTH—nephrolithiasis	0.000128	0.00498	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	0.000127	0.00493	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00011	0.00427	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—DGKH—nephrolithiasis	0.000109	0.00425	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000108	0.00421	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GRHPR—nephrolithiasis	0.000104	0.00404	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	0.000102	0.00398	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ADCY10—nephrolithiasis	0.000102	0.00397	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	0.000101	0.00393	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	9.95e-05	0.00387	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	9.92e-05	0.00386	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	9.82e-05	0.00382	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—AGXT—nephrolithiasis	9.25e-05	0.0036	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	8.7e-05	0.00339	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	8.68e-05	0.00338	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	8.59e-05	0.00334	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	7.92e-05	0.00308	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—SLC26A1—nephrolithiasis	7.86e-05	0.00306	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—APRT—nephrolithiasis	7.86e-05	0.00306	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	7.82e-05	0.00304	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	7.25e-05	0.00282	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	7.22e-05	0.00281	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	7.19e-05	0.0028	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	7.15e-05	0.00278	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	7.1e-05	0.00276	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	6.58e-05	0.00256	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	6.56e-05	0.00255	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	6.5e-05	0.00253	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.88e-05	0.00229	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	5.88e-05	0.00229	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.86e-05	0.00228	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	5.86e-05	0.00228	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.8e-05	0.00226	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	5.8e-05	0.00226	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—AQP1—nephrolithiasis	5.6e-05	0.00218	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	4.25e-05	0.00165	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	4.2e-05	0.00163	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PTH—nephrolithiasis	3.89e-05	0.00151	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PTH—nephrolithiasis	3.87e-05	0.00151	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PTH—nephrolithiasis	3.84e-05	0.00149	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	1.95e-05	0.00076	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	1.95e-05	0.000757	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	1.93e-05	0.00075	CbGpPWpGaD
